Work

Abstract CT143: First-in-human, multicenter study of SENTI-202, a CD33/FLT3 selective off-the-shelf logic gated CAR NK cell therapy in hematologic malignancies including AML: Correlative data

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct143

Authors: Muharrem Muftuoglu, Enping Hong, Stephen A. Strickland, Alireza Eghtedar, Gary Schiller, Nosha Farhadfar, Ashish R. Bajel, Farhad Ravandi, Mahesh Basyal, Li Li, Lawrence Naitmazi, Rochelle Emery, Brian S. Garrison, Timothy Lu, Kanya Rajangam, Michael Andreeff

Institutions: The University of Texas MD Anderson Cancer Center, Colorado Blood Cancer Institute, University of California, Los Angeles, Peter MacCallum Cancer Centre

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409822179

Cites:

Cited by: 5

Related to: 10